Therapy A-Z
Treatment approaches, explained in general terms.
8 entries
A
- Antibody-drug conjugatesTargeted delivery
Treatments that link an antibody to a cytotoxic payload, so delivery is directed towards cells carrying a particular target.
Target expression is usually assessed on tissue before an ADC is considered. Use requires specialist selection and monitoring, and side effects differ between products.
Read more
C
- CAR-T cell therapyCellular therapy
A cellular therapy considered in selected blood cancers, in which a patient's own immune cells are modified in a laboratory.
It is delivered only in specialist centres with intensive monitoring, and suitability is determined solely after detailed specialist assessment. Nothing on this website is a statement of suitability.
Read more- ChemotherapySystemic treatment
Systemic treatment given in cycles, used in curative, adjuvant, neoadjuvant and symptom-directed settings.
Regimen, schedule and supportive medication are clinical decisions. This website does not provide dosing or scheduling information.
Read more- Clinical trial participationResearch participation
Taking part in a research study, discussed only where a study is open, relevant and appropriate for the individual.
A trial review is not the same as eligibility or enrolment: eligibility is assessed by the team running the study, after screening and informed consent.
Read more
H
- Hormone therapySystemic treatment
Treatment directed at hormone signalling, considered in receptor-positive breast cancer and in prostate cancer.
It is often given over long periods, and the balance of benefit and side effects is reviewed during follow-up.
Read more
I
- ImmunotherapyImmune-directed treatment
Treatment that acts on immune regulation rather than on the cancer cell directly.
Use depends on the cancer type, relevant biomarkers and the individual clinical picture. Immune-related side effects require specific monitoring and management.
Read more
S
- Supportive and palliative treatmentSymptom-directed care
Symptom-directed treatment that can be provided alongside active cancer treatment.
It is not limited to end-of-life care, and a referral does not itself mean anticancer treatment is being stopped.
Read more
T
- Targeted therapyMolecularly directed treatment
Treatment directed at a specific molecular alteration in the cancer.
It can be considered when a relevant alteration is present, in the appropriate clinical context. The presence of an alteration does not by itself mean a particular treatment will work.
Read more
The A-Z directories provide general educational information. The relevance of a biomarker, test or therapy depends on the individual diagnosis and clinical context, and should be interpreted with a qualified healthcare professional. Nothing in this index is a treatment recommendation, a dosing instruction or a statement of suitability for any individual. Treatment selection requires specialist assessment.
Other indexes
Continue browsing.
Understanding the terms is a starting point, not a plan.
A consultation places these findings in the context of an individual clinical situation.